Kenya Urged to Include Analogue Insulin Pens in Health Benefits Package
MSF urges Kenya to include analogue insulin pens in the Social Health Authority benefits package to improve diabetes care and equitable access to treatment.... Read more.
Advanced AI-Enabled MRI Technology to Expand Across New England
Shields Health and GE HealthCare are expanding AI-enabled MRI technology across New England to support faster scans, high-quality imaging and improved patient experience.... Read more.
Dubai to develop ‘people-centred’ care and protection facilities for women, children
Dubai Municipality and DFWAC sign an agreement to develop human-centred care and protection facilities focused on safety, rehabilitation and wellbeing.... Read more.
Biotech Collaboration Aims to Advance Personalized Brain Cancer Therapy in Saudi Arabia
Northwest Biotherapeutics and SPIMACO have signed an MoU to explore the approval, commercialization, and localized manufacturing of DCVax-L personalized immunotherapy... Read more.
China-Pakistan Joint Lab Advances Smart Disaster Prevention Research
China and Pakistan have launched a joint smart disaster prevention laboratory to advance AI-driven infrastructure resilience, earthquake engineering, technology... Read more.
Africa CDC and WHO Urge Community-Led Action to Strengthen Ebola Response in DRC
Africa CDC and WHO have called for urgent community-led action to strengthen Ebola response efforts in the DRC, focusing on early detection, contact tracing, frontline... Read more.
Healthcare Group Reports AED2.79 Billion Revenue in H1 2026
Burjeel Holdings reported AED2.79 billion in H1 2026 revenue and over 3.7 million patient visits, driven by strong clinical performance, network expansion, and continued... Read more.
Qatar Launches Online Permit System for Travellers Carrying Controlled Medicines
Qatar has launched an online permit system allowing travellers to apply electronically for approval to carry controlled medicines, streamlining travel while strengthening... Read more.
Hikma Reports Strong H1 2026 Results, Reaffirms Full-Year Outlook
Hikma Pharmaceuticals reported 4% revenue growth to $1.728 billion in H1 2026, driven by strong branded sales, product launches and strategic investments while reaffirming... Read more.
Strategic Joint Venture to Accelerate Global Infant Nutrition Growth
HOCHDORF and Pharmalys Laboratories have launched Hochdorf Laboratories SA, a strategic joint venture to accelerate global growth and innovation in infant nutrition.... Read more.
